BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, January 27, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for Dec. 17, 2025

Dec. 17, 2025
Med-tech firms raising money in public or private financings, including: Ferronova, Fractyl Health, Nanit, Ultromics.
Read More

In the clinic for Dec. 17, 2025

Dec. 17, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Cellution Biologics, Cerapedics, Co-Diagnostics, Personalis.
Read More

Other news to note for Dec. 17, 2025

Dec. 17, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Baird Medical, Beyond Air, Biocerta Precision, Dacadoo, Femselect, GE Healthcare, Insightec, Lifeward, Neuropace, Population Health Partners, Shanghai Kohope, SOLVD, Spinol Medical Verita Neuro, Vaso Corp., Vaso Diagnostics, Vasohealthcare, Verita Healthcare.
Read More

Regulatory actions for Dec. 17, 2025

Dec. 17, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Celltivity, Clarius Mobile Health, CMR Surgial, Hyperfine, Medibeacon, Numares, Pathmaker Neurosystems, Rivanna Medical, Sleepres.
Read More

Regulatory actions for Dec. 16, 2025

Dec. 16, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Abpro, Algia, Amphastar, Anavex, Biocryst, Celltrion, Fibrogen, Fortress, Innoviva, Janssen, Lenz, Leo, LIB, Milestone, Moderna, Pilatus, Sanofi, Vanda.
Read More

Other news to note for Dec. 16, 2025

Dec. 16, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Adaptive, J&J, Neuronasal, Ophidion, Pfizer.
Read More

In the clinic for Dec. 16, 2025

Dec. 16, 2025
Clinical updates, including data readouts and publications: Argenx, Ascletis, Aviceda, Gilead, Immunome, Innocare, Kyverna, Orca, Palvella, Radiopharm.
Read More

Financings for Dec. 16, 2025

Dec. 16, 2025
Biopharmas raising money in public or private financings, including: Jade, Link Cell, Oniria, Swixx, Tiziana, Vor.
Read More

Appointments and advancements for Dec. 16, 2025

Dec. 16, 2025
New hires and promotions in the biopharma industry, including: Abeona, Hansa, Silence, Spruce.
Read More

Appointments and advancements for Dec. 17, 2025

Dec. 16, 2025
New hires and promotions in the med-tech industry, including: Aveta Medical, Koru Medical.
Read More
Previous 1 2 … 24 25 26 27 28 29 30 31 32 … 1744 1745 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 26, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 23, 2026.
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Dice spelling out D-E-A-L-?, yes, no

    Muted and missing M&As: JPM deals absent in 2026

    BioWorld
    For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
  • Woman taking medication for mental illness

    Sumitomo’s DSP-3456 exerts antidepressant-like effects

    BioWorld Science
    About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing